Carboplatin and Bevacizumab for Recurrent Ependymoma

NCT01295944 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Ependymoma
Anaplastic Ependymoma

Interventions

DRUG: Carboplatin
DRUG: Bevacizumab

Sponsor

National Cancer Institute (NCI)